Thomas DesRosier insider trades

Open-market stock purchases and sales by Thomas DesRosier, See Remarks at Seres Therapeutics, Inc, from SEC Form 4 filings since May 24, 2010.

Recent trades

DateStockTradeValue
May 18, 2026MCRB Seres Therapeutics, IncSold$595
May 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
May 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
May 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Mar 4, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Feb 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Feb 15, 2026MCRB Seres Therapeutics, IncSold$661
Feb 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Feb 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Nov 15, 2025MCRB Seres Therapeutics, IncSold$1.3K
Nov 15, 2025MCRB Seres Therapeutics, IncBought (not open market)—
Nov 15, 2025MCRB Seres Therapeutics, IncBought (not open market)—

Companies traded

  • MCRB Seres Therapeutics, Inc: 14 sales, last May 18, 2026
  • ARIA Ariad Pharmaceuticals Inc: other filings, last Mar 7, 2016
  • CBST Cubist Pharmaceuticals Inc: 1 sale, last Jan 21, 2015
  • GENZ Genzyme Corp: 1 sale, last Apr 4, 2011

Get free alerts when Thomas DesRosier files a new trade →